行情

GSK

GSK

葛兰素史克
NYSE

实时行情|Nasdaq Last Sale

39.85
+0.77
+1.96%
交易中 15:08 06/23 EDT
开盘
40.53
昨收
39.08
最高
40.58
最低
39.76
成交量
1,095.79万
成交额
--
52周最高
42.40
52周最低
33.26
市值
1,002.40亿
市盈率(TTM)
13.79
分时
5日
1月
3月
1年
5年
葛兰素史克首席执行官沃姆斯利在战略获得适度支持时争取时间
(Bloomberg) -- Emma Walmsley may have bolstered her position at the top of GlaxoSmithKline Plc, at least for now, following a lukewarm reaction to long-awaited plans to restructure the pharmaceutical giant after years of underperformance.With a potential a...
Bloomberg · 40分钟前
葛兰素史克 (GlaxoSmithKline) 在激进投资者埃利奥特 (Elliott) 出现之际谈论增长前景
marketwatch.com · 3小时前
葛兰素史克刚刚宣布削减股息。为什么它的股票在上涨。
The spinoff of the consumer health business will allow the remaining company to increase sales by more than 5% a year for the next half decade, management said.
Barrons.com · 4小时前
在葛兰素史克和资源名称的推动下,伦敦股市攀升
The FTSE 100 was outperforming European rival indexes on Wednesday, helped by higher oil prices and as shares of GlaxoSmithKline surged after an investor meeting.
MarketWatch · 4小时前
在激进基金 Elliott 的压力下,葛兰素史克公布了雄心勃勃的增长目标。但这足够了吗?
marketwatch.com · 5小时前
随着消费者业务的分裂,葛兰素史克首席执行官誓言“增长的阶梯式变化”
British pharmaceutical giant GlaxoSmithKline faces a crunch meeting with investors after announcing a new strategy for the next decade.
CNBC.com · 6小时前
葛兰素史克承诺增长,但将削减股息
marketwatch.com · 6小时前
葛兰素史克首席执行官谈剥离消费者保健业务
GlaxoSmithKline's stock rose 3.5% in the premarket Wednesday after it detailed plans to spin out its consumer health-care business into a separate company. Glaxo will eventually receive an $11 billion payment from the new company. GlaxoSmithKline CEO Emma ...
CNBC.com · 6小时前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解GSK最新的财务预测,通过GSK每股收益,每股净资产,每股现金流等数据分析葛兰素史克近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测GSK价格均价为49.17,最高价位54.50,最低价为42.00。
EPS
机构持股
总机构数: 1,103
机构持股: 3.45亿
持股比例: 13.71%
总股本: 25.16亿
类型机构数股数
增持
291
4,977.43万
建仓
50
1,307.76万
减持
286
3,422.12万
平仓
86
356.20万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.45%
制药与医学研究
-0.38%
高管信息
Non-Executive Chairman/Independent Director
Jonathan Symonds
Chief Executive Officer/Executive Director
Emma Walmsley
Chief Financial Officer/Executive Director
Iain Mackay
Corporate Executive
Roger Connor
Corporate Executive
Brian McNamara
Corporate Executive
Luke Miels
Corporate Executive
Abbas Hussain
Corporate Executive
Regis Simard
Corporate Executive
Phil Thomson
Corporate Executive
Deborah Waterhouse
Senior Vice President/General Counsel
James Ford
Senior Vice President/Director of Human Resources
Diana Conrad
Senior Vice President
Nick Hirons
Senior Vice President
Sally Jackson
Chief Technology Officer
Karenann Terrell
Chief Scientific Officer/Executive Director
Hal Barron
Other
David Redfern
Non-Executive Independent Director
Manvinder Banga
Secretary
Victoria Whyte
Non-Executive Independent Director
Charles Bancroft
Non-Executive Independent Director
Marvinder Banga
Non-Executive Independent Director
Anne Beal
Non-Executive Independent Director
Vivienne Cox
Non-Executive Independent Director
Lynn Elsenhans
Non-Executive Independent Director
Laurie Glimcher
Non-Executive Independent Director
Jesse Goodman
Non-Executive Independent Director
Judy Lewent
Non-Executive Independent Director
Urs Rohner
公告日期
每股分红
除权日期
2021/05/04
每股分红:USD 0.5195486
2021/05/20
--
每股分红:USD 0.6291689
2021/02/18
--
每股分红:USD 0.5091635
2020/11/12
2020/07/29
每股分红:USD 0.4854219
2020/08/13
2020/04/29
每股分红:USD 0.4664139
2020/05/14
2020/02/05
每股分红:USD 0.5594826
2020/02/20
--
每股分红:USD 0.4923352
2019/11/14
--
每股分红:USD 0.4583283
2019/08/08
--
每股分红:USD 0.465536
2019/05/16
2019/02/07
每股分红:USD 0.594243
2019/02/21
2018/11/01
每股分红:USD 0.479
2018/11/15
2018/07/25
每股分红:USD 0.491
2018/08/09
2018/04/26
每股分红:USD 0.525
2018/05/10
2018/02/07
每股分红:USD 0.647
2018/02/22
2017/10/25
每股分红:USD 0.509
2017/11/09
2017/07/26
每股分红:USD 0.496
2017/08/09
2017/07/11
每股分红:USD 0.485
2017/05/10
2017/04/11
每股分红:USD 0.566
2017/02/22
2017/01/10
每股分红:USD 0.457
2016/11/02
2016/10/11
每股分红:USD 0.462
2016/08/10
GSK 简况
GlaxoSmithKline PLC是一家全球性医疗保健公司。该公司经营三个业务部门:制药部门和疫苗部门。该公司专注于六个领域的研究:呼吸系统疾病、人类免疫缺陷病毒(HIV)病毒/传染病、疫苗、免疫炎症、肿瘤和罕见疾病。该公司生产一系列处方药和疫苗。制药部门探索发现、开发并商业化治疗一系列急性和慢性疾病的药物。疫苗部门为所有年龄段人群(从婴儿、青少年到成年人和老年人)提供疫苗。该公司有一系列呼吸道和HIV病毒药物。其制药业务包括呼吸系统产品、HIV产品、特色产品以及经典和已确立的产品。其疫苗业务包括40多种儿科、青少年、成人、老年人和旅行疫苗。

微牛提供GlaxoSmithKline plc (ADR)(NYSE-GSK)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的GSK股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易GSK股票基本功能。